Published in World J Urol on February 01, 2000
Increased survival of muscle stem cells lacking the MyoD gene after transplantation into regenerating skeletal muscle. Proc Natl Acad Sci U S A (2007) 1.27
Sphincter contractility after muscle-derived stem cells autograft into the cryoinjured anal sphincters of rats. Dis Colon Rectum (2008) 0.96
Advances in stem cell therapy for the lower urinary tract. World J Stem Cells (2010) 0.95
Retracted Transurethral ultrasonography-guided injection of adult autologous stem cells versus transurethral endoscopic injection of collagen in treatment of urinary incontinence. World J Urol (2007) 0.95
Isolation, culture, and transplantation of muscle satellite cells. J Vis Exp (2014) 0.89
Culture of skeletal myoblasts from human donors aged over 40 years: dynamics of cell growth and expression of differentiation markers. J Transl Med (2005) 0.87
Human amniotic fluid stem cell-derived muscle progenitor cell therapy for stress urinary incontinence. J Korean Med Sci (2012) 0.84
Human umbilical cord blood mononuclear cell transplantation in rats with intrinsic sphincter deficiency. J Korean Med Sci (2010) 0.83
Cell-based therapy for urinary incontinence. Korean J Urol (2010) 0.78
Autologous transplantation of adult adipose derived stem cells into rabbit urethral wall. Int Urogynecol J (2010) 0.76
Two differentially structured collagen scaffolds for potential urinary bladder augmentation: proof of concept study in a Göttingen minipig model. J Transl Med (2017) 0.75
Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol (2000) 2.75
Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol (1998) 2.57
Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant (1994) 1.78
Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells. Hum Gene Ther (1994) 1.74
Muscle-derived stem cells. Gene Ther (2002) 1.60
Growth factors improve muscle healing in vivo. J Bone Joint Surg Br (2000) 1.57
Noninvasive urodynamic evaluation of bladder outlet obstruction using Doppler ultrasonography. Urology (2000) 1.54
Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol (2001) 1.54
The use of an antifibrosis agent to improve muscle recovery after laceration. Am J Sports Med (2001) 1.46
1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.45
Flow cytometric characterization of myogenic cell populations obtained via the preplate technique: potential for rapid isolation of muscle-derived stem cells. Hum Gene Ther (2001) 1.42
Long-term self-renewal of postnatal muscle-derived stem cells. Mol Biol Cell (2005) 1.42
Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability. J Urol (1999) 1.41
Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel. J Clin Endocrinol Metab (1990) 1.37
The effects of periurethral muscle-derived stem cell injection on leak point pressure in a rat model of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2003) 1.32
Effect of intravesical nitric oxide therapy on cyclophosphamide-induced cystitis. J Urol (1999) 1.32
Bladder and sphincter behavior in patients with spinal cord lesions. J Urol (1991) 1.28
Urodynamics of spinal cord injury. Urol Clin North Am (1996) 1.25
Pseudocyanotic pigmentation of the skin induced by amiodarone: a light and electron microscopic study. Can Med Assoc J (1975) 1.21
Muscle-derived stem cells: characterization and potential for cell-mediated therapy. Blood Cells Mol Dis (2002) 1.19
The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor. J Urol (2001) 1.19
Suturing versus immobilization of a muscle laceration. A morphological and functional study in a mouse model. Am J Sports Med (1999) 1.19
Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol (2001) 1.18
Neural control of the urethra. Scand J Urol Nephrol Suppl (2001) 1.17
Development of noninvasive velocity flow video urodynamics using Doppler sonography. Part II: clinical application in bladder outlet obstruction. J Urol (1998) 1.16
Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone (1999) 1.16
Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg Am (2001) 1.15
Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum Gene Ther (1996) 1.14
The use of adeno-associated virus to circumvent the maturation-dependent viral transduction of muscle fibers. Hum Gene Ther (2000) 1.14
New use of a three-dimensional pellet culture system for human intervertebral disc cells: initial characterization and potential use for tissue engineering. Spine (Phila Pa 1976) (2001) 1.14
Review: gene- and stem cell-based therapeutics for bone regeneration and repair. Tissue Eng (2007) 1.12
The involvement of the tetrodotoxin-resistant sodium channel Na(v)1.8 (PN3/SNS) in a rat model of visceral pain. J Neurosci (2001) 1.11
Development of noninvasive velocity flow video urodynamics using Doppler sonography. Part I: Experimental urethra. J Urol (1998) 1.11
Analysis of rabbit articular cartilage repair after chondrocyte implantation using optical coherence tomography. Osteoarthritis Cartilage (2003) 1.11
Mechanisms of muscle stem cell expansion with cytokines. Stem Cells (2002) 1.10
Use of growth factors to improve muscle healing after strain injury. Clin Orthop Relat Res (2000) 1.10
Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells. Gene Ther (2005) 1.10
Early predictors of bladder recovery and urodynamics after spinal cord injury. Neurourol Urodyn (1998) 1.09
Preliminary results of myoblast injection into the urethra and bladder wall: a possible method for the treatment of stress urinary incontinence and impaired detrusor contractility. Neurourol Urodyn (2000) 1.07
Modeling stem cell population growth: incorporating terms for proliferative heterogeneity. Stem Cells (2003) 1.06
Removal of UroLume endoprosthesis: experience of the North American Study Group for detrusor-sphincter dyssynergia application. J Urol (2000) 1.06
Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia. J Urol (2000) 1.05
Ex vivo gene therapy to produce bone using different cell types. Clin Orthop Relat Res (2000) 1.04
Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction. Gene Ther (2002) 1.04
Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants. Gene Ther (1994) 1.03
The effect of platelet-rich plasma on the regenerative therapy of muscle derived stem cells for articular cartilage repair. Osteoarthritis Cartilage (2012) 1.02
Analysis of the afferent limb of the vesicovascular reflex using neurotoxins, resiniferatoxin and capsaicin. Am J Physiol Regul Integr Comp Physiol (2001) 1.02
The Pittsburgh Tissue Engineering Initiative. Clin Plast Surg (1999) 1.01
Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: potential treatment for diabetic bladder dysfunction. J Urol (2001) 1.01
Inhibition of the IKK/NF-κB pathway by AAV gene transfer improves muscle regeneration in older mdx mice. Gene Ther (2010) 1.00
Changes in micturition after spinal cord injury in conscious rats. Urology (1999) 1.00
Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy. Gene Ther (2000) 0.99
Development of approaches to improve the healing following muscle contusion. Cell Transplant (1999) 0.98
Muscle injuries and repair: the role of prostaglandins and inflammation. Histol Histopathol (2003) 0.98
Molecular marker for development of interstitial cystitis in rat model: isoactin gene expression. J Urol (1997) 0.98
Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic protein-2. J Bone Joint Surg Br (2002) 0.97
Modified Burch colposuspension for stress urinary incontinence in females. Surg Gynecol Obstet (1993) 0.95
Neural control of the urethra and development of pharmacotherapy for stress urinary incontinence. BJU Int (2003) 0.95
Effects of cigarette smoke components on in vitro chemotaxis of human polymorphonuclear leukocytes. Infect Immun (1977) 0.94
Limb lengthening promotes muscle growth. J Orthop Res (1997) 0.94
The role of receptors in the maturation-dependent adenoviral transduction of myofibers. Gene Ther (2001) 0.94
Viral gene delivery to skeletal muscle: insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors. Hum Gene Ther (1997) 0.94
Effect of OROS controlled-release delivery on the pharmacokinetics and pharmacodynamics of oxybutynin chloride. Br J Clin Pharmacol (2001) 0.93
Gene therapy of bladder pain with herpes simplex virus (HSV) vectors expressing preproenkephalin (PPE). Urology (2001) 0.93
Long-term results of augmentation cystoplasty in spinal cord injury patients. Spinal Cord (2000) 0.93
Expression of major histocompatibility complex antigens on human myoblasts. Transplant Proc (1991) 0.92
Influence of glutamate receptor antagonists on micturition in rats with spinal cord injury. Exp Neurol (1999) 0.92
The effect of urinary tract reconstruction on neurologically impaired women previously treated with an indwelling urethral catheter. J Urol (1996) 0.92
Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles. Gene Ther (1998) 0.92
Persistence and survival of autologous muscle derived cells versus bovine collagen as potential treatment of stress urinary incontinence. J Urol (2001) 0.91
Herpes simplex virus vector-mediated gene delivery of glutamic acid decarboxylase reduces detrusor overactivity in spinal cord-injured rats. Gene Ther (2009) 0.91
Generation, validation, and large scale production of adenoviral recombinants with large size inserts such as a 6.3 kb human dystrophin cDNA. J Virol Methods (1997) 0.91
Injection of skeletal muscle-derived cells into the penis improves erectile function. Int J Impot Res (2005) 0.91
Oral gabapentin (neurontin) treatment of refractory genitourinary tract pain. Tech Urol (2001) 0.91
Antibody formation after myoblast transplantation in Duchenne-dystrophic patients, donor HLA compatible. Transplant Proc (1993) 0.90
Muscle-derived cell transplantation and differentiation into lower urinary tract smooth muscle. Urology (2001) 0.90
Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury. Gene Ther (2008) 0.89
Isolation of myogenic progenitor populations from Pax7-deficient skeletal muscle based on adhesion characteristics. Gene Ther (2008) 0.89
Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injury. Gene Ther (2007) 0.89
Myoblast transplantation produced dystrophin-positive muscle fibres in a 16-year-old patient with Duchenne muscular dystrophy. Clin Sci (Lond) (1991) 0.88
Gene therapy strategies for urological dysfunction. Trends Mol Med (2001) 0.88
Use of fluorescent latex microspheres (FLMs) to follow the fate of transplanted myoblasts. J Histochem Cytochem (1993) 0.86
Lyme cystitis and neurogenic bladder dysfunction. Lancet (1992) 0.86
High incidence of occult neurogenic bladder dysfunction in neurologically intact patients with thoracolumbar spinal injuries. J Urol (1998) 0.86
Reliability of color Doppler ultrasound urodynamics in the evaluation of bladder outlet obstruction. Urology (2000) 0.86
Muscle stem cells can act as antigen-presenting cells: implication for gene therapy. Gene Ther (2004) 0.85
The use of relaxin improves healing in injured muscle. Ann N Y Acad Sci (2005) 0.85
Spinal cord injury and bladder recovery. Arch Phys Med Rehabil (1996) 0.85
Myoblast-mediated gene transfer to the joint. J Orthop Res (1997) 0.85
Myogenic cellular transplantation and regeneration: sorting through progenitor heterogeneity. Panminerva Med (2004) 0.85
Pharmacologic and potential biologic interventions to restore bladder function after spinal cord injury. Curr Opin Neurol (2000) 0.85
Autologous primary muscle-derived cells transfer into the lower urinary tract. Tissue Eng (2001) 0.85
Muscle cell-mediated gene delivery to the rotator cuff. Tissue Eng (2003) 0.85
Extended tropism of an adenoviral vector does not circumvent the maturation-dependent transducibility of mouse skeletal muscle. J Gene Med (2000) 0.84